Smith DL - Search Results

1

The path of least resistance: aggressive or moderate treatment?

Kouyos RD, Metcalf CJ, Birger R, Klein EY, Abel zur Wiesch P, Ankomah P, Arinaminpathy N, Bogich TL, Bonhoeffer S, Brower C, Chi-Johnston G, Cohen T, Day T, Greenhouse B, Huijben S, Metlay J, Mideo N, Pollitt LC, Read AF, Smith DL, Standley C, Wale N, Grenfell B. Kouyos RD, et al. Among authors: smith dl. Proc Biol Sci. 2014 Nov 7;281(1794):20140566. doi: 10.1098/rspb.2014.0566. Proc Biol Sci. 2014. PMID: 25253451 Free PMC article.

2

Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem.

Smith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA. Smith DL, et al. Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3709-14. doi: 10.1073/pnas.0400456101. Epub 2004 Feb 25. Proc Natl Acad Sci U S A. 2004. PMID: 14985511 Free PMC article.

3

Synchrony, waves, and spatial hierarchies in the spread of influenza.

Viboud C, Bjørnstad ON, Smith DL, Simonsen L, Miller MA, Grenfell BT. Viboud C, et al. Among authors: smith dl. Science. 2006 Apr 21;312(5772):447-51. doi: 10.1126/science.1125237. Epub 2006 Mar 30. Science. 2006. PMID: 16574822

4

Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005.

Klein E, Smith DL, Laxminarayan R. Klein E, et al. Among authors: smith dl. Emerg Infect Dis. 2007 Dec;13(12):1840-6. doi: 10.3201/eid1312.070629. Emerg Infect Dis. 2007. PMID: 18258033 Free PMC article.

5

Clinically immune hosts as a refuge for drug-sensitive malaria parasites.

Klein EY, Smith DL, Boni MF, Laxminarayan R. Klein EY, et al. Among authors: smith dl. Malar J. 2008 Apr 25;7:67. doi: 10.1186/1475-2875-7-67. Malar J. 2008. PMID: 18439283 Free PMC article.

6

Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999-2006.

Klein E, Smith DL, Laxminarayan R. Klein E, et al. Among authors: smith dl. Emerg Infect Dis. 2009 Dec;15(12):1925-30. doi: 10.3201/eid1512.081341. Emerg Infect Dis. 2009. PMID: 19961671 Free PMC article.

7

Should new antimalarial drugs be subsidized?

Laxminarayan R, Parry IW, Smith DL, Klein EY. Laxminarayan R, et al. Among authors: smith dl. J Health Econ. 2010 May;29(3):445-56. doi: 10.1016/j.jhealeco.2010.03.002. Epub 2010 Mar 7. J Health Econ. 2010. PMID: 20381182

8

Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty.

Smith DL, Klein EY, McKenzie FE, Laxminarayan R. Smith DL, et al. Malar J. 2010 Jul 23;9:217. doi: 10.1186/1475-2875-9-217. Malar J. 2010. PMID: 20653960 Free PMC article.

9

"One-size-fits-all"? Optimizing treatment duration for bacterial infections.

Geli P, Laxminarayan R, Dunne M, Smith DL. Geli P, et al. Among authors: smith dl. PLoS One. 2012;7(1):e29838. doi: 10.1371/journal.pone.0029838. Epub 2012 Jan 11. PLoS One. 2012. PMID: 22253798 Free PMC article.

10

Superinfection and the evolution of resistance to antimalarial drugs.

Klein EY, Smith DL, Laxminarayan R, Levin S. Klein EY, et al. Among authors: smith dl. Proc Biol Sci. 2012 Sep 22;279(1743):3834-42. doi: 10.1098/rspb.2012.1064. Epub 2012 Jul 11. Proc Biol Sci. 2012. PMID: 22787024 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,627 results

Search Page